Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available
Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression. At that time, we were told that Zulresso would be available in June 2019. [...]